Cardiac cholinergic NO-cGMP signaling following acute myocardial infarction and nNOS gene transfer.

Cardiac cholinergic NO-cGMP signaling following acute myocardial infarction and nNOS gene transfer.

Myocardial infarction (MI) is associated with oxidative stress, which may cause cardiac autonomic impairment. We tested the hypothesis that acute MI disrupts cardiac cholinergic signaling by impairing nitric oxide (NO)-cGMP modulation of acetylcholine (ACh) release and whether the restoration of thi...

Full description

Bibliographic Details
Main Authors:	Dawson, T, Li, D, Woodward, T, Barber, Z, Wang, L, Paterson, D
Format:	Journal article
Language:	English
Published:	2008

Similar Items

Myocardial nNOS-derived NO regulates excitation-contraction coupling via differential and cGMP-independent effects on protein phosphorylation
by: Zhang, M, et al.
Published: (2012)

Cardiac nNOS regulates myocardial relaxation by stimulating phospholamban phosphorylation
by: Zhang, Y, et al.
Published: (2005)

Cardiac nNOS regulates myocardial relaxation by stimulating phospholamban phosphorylation
by: Zhang, Y, et al.
Published: (2005)

nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction
by: Dawson, D, et al.
Published: (2005)

nNOS gene deletion exacerbates pathological left ventricular remodelling and functional deterioration after myocardial infarction
by: Dawson, D, et al.
Published: (2005)

nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction.
by: Dawson, D, et al.
Published: (2005)

cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism.
by: Takimoto, E, et al.
Published: (2005)

Impaired cAMP-cGMP cross-talk during cardiac sympathetic dysautonomia.
by: Bardsley, E, et al.
Published: (2016)

Targeted nNOS gene transfer into the cardiac vagus rapidly increases parasympathetic function in the pig.
by: Heaton, D, et al.
Published: (2005)

Cardiac nitric oxide: emerging role for nNOS in regulating physiological function.
by: Danson, E, et al.
Published: (2005)

NO-cGMP pathway facilitates vagal neurotransmission and bradycardia
by: Herring, N, et al.
Published: (2001)

Discordant response to exercise training in nnos knockout mice: Differential role of nNOS on exercise performance versus cardiac hypertrophy
by: de Bono, J, et al.
Published: (2007)

Natriuretic peptides like NO facilitate cardiac vagal neurotransmission and bradycardia via a cGMP pathway.
by: Herring, N, et al.
Published: (2001)

Effect of disruption of the nNOS gene on myocardial calcium current and contraction
by: Sears, C, et al.
Published: (2001)

Possible regulation of cardiac ADP-ribosyl cyclase by cGMP-dependent mechanisms
by: Solanki, P, et al.
Published: (2000)

NO-cGMP dependent pathway and the modulation of vagal control of heart rate
by: Herring, N, et al.
Published: (2000)

Role of nNOS in the automatic control of cardiac excitability in cardiac physiological and pathophysiological states
by: Heaton, D, et al.
Published: (2005)

Selective gene deletion of the neuronal nitric oxide synthase (nNOS) accelerates pathological left ventricular remodelling and functional deterioration after myocardial infarction (MI)
by: Dawson, D, et al.
Published: (2005)

FRET-based cyclic GMP biosensors measure low cGMP concentrations in cardiomyocytes and neurons
by: Calamera, G, et al.
Published: (2019)

FRET-based cyclic GMP biosensors measure low cGMP concentrations in cardiomyocytes and neurons
by: Calamera, G, et al.
Published: (2019)

Reduced phospholamban phosphorylation is responsible for impaired myocardial relaxation in nNOS(-/-) mice
by: Zhang, Y, et al.
Published: (2006)

Reduced phospholamban phosphorylation is responsible for impaired myocardial relaxation in nNOS(-/-) mice
by: Zhang, Y, et al.
Published: (2005)

Adenoviral nNOS gene transfer into the cardiac vagus increases protein expression within 9 hours and enhances vagal responsiveness in the pig
by: Paterson, D, et al.
Published: (2004)

Are myocardial eNOS and nNOS involved in the beta-adrenergic and muscarinic regulation of inotropy? A systematic investigation.
by: Martin, SR, et al.
Published: (2006)

Sodium channel and nNOS expression following inferior alveolar nerve
by: Davies, S, et al.
Published: (2001)

nNOS expression following inferior alveolar nerve injury in the ferret.
by: Davies, S, et al.
Published: (2004)

cAMP and cGMP signaling cross-talk: role of phosphodiesterases and implications for cardiac pathophysiology.
by: Zaccolo, M, et al.
Published: (2007)

Plasma catecholamines in patients with acute myocardial infarction and in cardiac arrest.
by: Little, R, et al.
Published: (1985)

Differential role of nNOS in heart rate regulation between rest and exercise
by: Adlam, D, et al.
Published: (2007)

Tetrahydrobiopterin (BH4), a cofactor for nNOS, restores gastric emptying and nNOS expression in female diabetic rats.
by: Gangula, P, et al.
Published: (2010)

Sulphonylurea-sensitive channels and NO-cGMP pathway modulate the heart rate response to vagal nerve stimulation in vitro.
by: Almond, S, et al.
Published: (2000)

Neuronal NOS (nNOS) is expressed in human osteocytes: Multiple pathways of NO regulation?
by: Caballero, A, et al.
Published: (2002)

Constitutive NO production in the myocardium: More than cGMP signalling
by: Casadei, B
Published: (2008)

The cardiac lymphatic system stimulates resolution of inflammation following myocardial infarction
by: Vieira, J, et al.
Published: (2018)

Activation of sulphonylurea-sensitive channels and the NO-cGMP pathway decreases the heart rate response to sympathetic nerve stimulation.
by: Mohan, R, et al.
Published: (2000)

Cardiomyocyte-targeted overexpression of GTP cyclohydrolase-1 increases nNOS activity and hastens myocardial relaxation
by: Carnicer, R, et al.
Published: (2011)

Compartmentalized phosphodiesterase-2 activity blunts beta-adrenergic cardiac inotropy via an NO/cGMP-dependent pathway.
by: Mongillo, M, et al.
Published: (2006)

NO-cGMP pathway increases the hyperpolarisation-activated current, I(f), and heart rate during adrenergic stimulation.
by: Herring, N, et al.
Published: (2001)

Fibulin-3 is necessary to prevent cardiac rupture following myocardial infarction
by: Murtha, LA, et al.
Published: (2023)

Inhibition of myocardial cathepsin-L release during reperfusion following myocardial infarction improves cardiac function and reduces infarct size
by: He, W, et al.
Published: (2021)